SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148077
Filing Date
2017-04-28
Accepted
2017-04-28 16:02:09
Documents
5
Period of Report
2017-06-22
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d353254ddef14a.htm DEF 14A 321539
2 GRAPHIC g3532541.jpg GRAPHIC 103587
3 GRAPHIC g3532542.jpg GRAPHIC 70475
4 GRAPHIC g353254g18h70.jpg GRAPHIC 43482
5 GRAPHIC g353254snap13.jpg GRAPHIC 451628
  Complete submission text file 0001193125-17-148077.txt   1244660
Mailing Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005
Business Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005 678-270-4005
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37783 | Film No.: 17795325
SIC: 2834 Pharmaceutical Preparations